The unprecedented increase in drug overdose deaths in the U.S., long believed to be driven by access to legal and illegal ...

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of ...

The EUDA director said people using multiple drugs at once, violence, and political polarisation are key challenges for 2025.

Purdue Pharma's earlier settlement plan included a $6 billion contribution from the Sacklers in exchange for immunity from all civil opioid claims.

Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what ...

OIP is a common adverse effect of therapeutic use of opioid medications that can have a major impact on patients ... Of the studies included in this review, most investigated the effects of ...

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in the ... in which it also suffered a major defeat in the US courts over patent ...

It follows threats by Trump to levy import taxes of 25% on Mexico and Canada, accusing them of allowing undocumented migrants and drugs into the US.

Passing the Alternatives to PAIN Act would be an excellent way for Trump to uphold his promise to “Make America Healthy Again ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...